References
- Furst DE. The rational use of methotrexate in rheumatoid arthritis and other rheumatic diseases. Br J Ftheumatol 1997;36:1196–204.
- Gutierrez-Urena S, Molina JF, Garcia CO, Cuellar ML, Espinoza LR. Pancytopenia secondary to methotrexate therapy in rheuma-toid arthritis. Arthritis Rheum 1996;39:272–6.
- Schroder JO, Schwab UM, Schnabel A, Asbeck F, Zurborn K-H, Gross WL, et al. Haufung MTX-assoziierter Zytopenien bei alteren Patienten. Dtsch Arzteblatt 1996;93:257–8.
- Berthelot JM, Maugars Y, Hamidou M, Chiffoleau A, Barrier J, Grolleau JY, et al. Pancytopenia and severe cytopenia induced by low-dose methotrexate. Eight case-reports and a review of one hundred cases from the literature (with twenty-four deaths). Rev Rheum Engl Ed 1995;62:477–86.
- Yasuda M, Suenaga Y, Kihara T, Akamine Y. Methotrexate-induced bone marrow failure in patients with rheumatoid arthritis. Review of both overseas and domestic reports (in Japanese). Iryo 2001;55:311–21.